The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters

Respiratory Medicine

Volumn 107, Issue 9, 2013, Pages 1393-1399

  Ramlal, S K ^a   Visser, F J ^b   Hop, W C J ^c   Dekhuijzen, P N R ^d   Heijdra, Y F ^d  

^a IJSSELLAND HOSPITAL   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aerochamber plus; COPD; FEV1; ILPs; Nebulizer; VAS score

Indexed keywords

IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;

ADULT; AEROCHAMBER; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MEDICAL NEBULIZER; PEAK INSPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY THERAPEUTIC DEVICE; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; VISUAL ANALOG SCALE; VITAL CAPACITY;

AEROCHAMBER PLUS; COPD; FEV(1); ILPS; NEBULIZER; VAS SCORE;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DRUG COMBINATIONS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84883049205     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.05.008     Document Type: Article

References (40)

1. Aerosol consensus statement: Consensus Conference on Aerosol Delivery Chest 100 1991 1106 1109
2. H. Mestitz, J.M. Copland, and C.F. McDonald Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler terbutaline in chronic airflow obstruction Chest 96 1989 1237 1240
3. K.A. Gunawardena, A.P. Smith, and J. Shankleman A comparison of metered dose inhalers with nebulizers for the delivery of ipratropium bromide in domiciliary practice Br J Dis Chest 80 1986 170 178
4. S.C. Jenkins, R.W. Heaton, T.J. Fulton, and J. Moxham Comparison or domiciliary nebulized salbutamol and salbutamol from a metered dose inhaler in stable chronic airflow limitation Chest 91 1987 804 807
5. M.B. Dolovich, R.C. Ahrens, D.R. Hess, P. Anderson, R. Dhand, and J.L. Rau Device selection and outcomes of aerosol therapy: evidence-based guidelines Chest 127 2005 335 371
6. A.H. Idris, M.F. McDermott, J.C. Raucci, A. Morrabel, S. McGorray, and L. Hendeles Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer Chest 103 1993 665 672
7. M.O. Turner, A. Patel, S. Ginsburg, and J.M. FitzGerald Bronchodilator delivery in acute airflow obstruction: a meta-analysis Arch Intern Med 157 1997 1736 1744
8. B.R. O'Driscoll, E.A. Kay, R.J. Taylor, H. Weatherby, M.C.P. Chetty, and A. Bernstein A long-term prospective assessment of home nebulizer treatment Respir Med 86 1992 317 325
9. R.S. Wilson, and S.J. Connellan Domiciliary nebulized salbutamol solution in severe chronic airway obstruction Thorax 35 1980 873 876
10. J.F. Morrison, P.C. Jones, and M.F. Muers Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation Eur Respir J 5 1992 424 429
11. J.M. Goldman, C. Teale, and M.F. Muers Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy Respir Med 86 1992 33 38
12. A. Noseda, J. Schmerber, T. Prigogine, and J.C. Yernault How do patients with either asthma or COPD perceive acute bronchodilation? Eur Respir J 6 1993 6636 6644
13. A. Noseda, J. Schmerber, T. Prigogine, and J.C. Yernault Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD Eur Respir J 5 1992 1043 1053
14. C. Taube, B. Lehnigk, K. Paasch, D.K. Kirsten, R.A. Jorres, and H. Magnussen Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 216 220
15. L. Puente-Maestu, and W.W. Stringer Hyperinflation and its management in COPD Int J Chron Obstruct Pulmon Dis 1 2006 381 400
16. M.F. Newton, D.E. O'Donnell, and L. Forkert Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation Chest 121 2002 1042 1050
17. C. Tantucci, A. Duguet, T. Similowski, M. Zelter, J.P. Derenne, and J. Milic-Emili Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients Eur Respir J 12 1998 799 804
18. C. Taube, F. Kanniess, L. Gronke, K. Richter, M. Mucke, and K. Paasch Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma Respir Med 97 2003 568 577
19. C. Taube, O. Holz, M. Mucke, R.A. Jorres, and H. Magnussen Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1810 1815
20. C. Taube, L. Rydzy, A. Eich, S. Korn, O. Kornmann, and M. Sebastian Use of a portable device to record maximum inspiratory flow in relation to dyspnea in patients with COPD Respir Med 105 2011 316 321
21. P.M. Calverley Dynamic hyperinflation: is it worth measuring? Proc Am Thorac Soc 3 2006 239 244
22. D.E. O'Donnell, M. Lam, and K.A. Webb Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease Am J Respir Crit Care Med 158 1998 1557 1565
23. D.E. O'Donnell, L. Forkert, and K.A. Webb Evaluation of bronchodilator responses in patients with irreversible emphysema Eur Respir J 18 2001 914 920
24. D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, and B. Aguilaniu Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD Eur Respir J 23 2004 832 840
25. S.K. Ramlal, F. Visser, W. Hop, R. Dekhuijzen, and Y. Heijdra Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD Respir Physiolo Neurobiol 173 2010 58 63
26. R.A. Pauwels, A.S. Buist, P.M.A. Calverely, C.R. Jenkens, and S.S. Hurd Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease (GOLD) workshop summary Am J Respir Crit Care Med 163 2001 1256 1276
27. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 152 1995 S72 S120
28. B.R. Celli, W. MacNee ATS/ERS Task Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
29. P.H. Quanjer, and G.J. Tammeling Summary of recommendations Bull Eur Physiopathol Respir 19 Suppl. 5 1983 7 10
30. J. Roca, F. Burgos, J. Sunyer, M. Saez, S. Chinn, and J.M. Anto References values for forced spirometry. Group of the European Community Respiratory Health Survey Eur Respir J 11 1998 1354 1362
31. 1 values in chronic obstructive pulmonary disease Respiration 76 2008 46 52
32. F. Visser, S.K. Ramlal, B. Pelzer, R. Dekhuijzen, and Y. Heijdra Random variation of inspiratory lung function parameters in patients with COPD: a diagnostic accuracy study BMC Pulm Med 10 2010 28
33. J.B. Fink Humidity and aerosol therapy J.M. Cairo, S.P. Pilbeam, Mosby's respiratory care equipment 2010 Mosby-Elsevier Inc. St. Louis, MO 91 140
34. D.E. Geller Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler Respir Care 50 2005 1313 1321
35. C. O'Callaghan, J. Lynch, and C. Robertson Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation and avoiding multiple actuations of drug Thorax 48 1993 603 606
36. S.P. Newman, D. Pavia, F. Morén, N.F. Sheahan, and S.W. Clarke Deposition of pressurized aerosols in the human respiratory tract Thorax 36 1981 52 55
37. B.M.Z. Zainudin, M. Biddiscombe, S.E.J. Tolfree, M. Short, and S.G. Spiro Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from pressurized metered dose inhaler, as dry powder inhaler and as a nebulized solution Thorax 45 1990 469 473
38. E. Boni, L. Corda, D. Franchini, P. Chiroli, G.P. Damiani, and L. Pini Volume effect and exertional dyspnea after bronchodilator in COPD patients with and without expiratory flow limitation at rest Thorax 57 2002 528 532
39. R. Pellegrino, and V. Brusasco Lung hyperinflation and flow limitation in chronic airway obstruction Eur Respir J 10 1997 543 549
40. F. Di Marco, J. Milic-Emili, B. Boveri, P. Carlucci, P. Santus, and F. Casanova Effect of inhaled bronchodilators on inspiratory capacity and dyspnea at rest in COPD Eur Respir J 21 2003 86 94